Aastrom Biosciences Inc (NASDAQ:ASTM)

CAPS Rating: 1 out of 5

The regenerative medicine company engaged in clinical development of autologous cell products for the repair or regeneration of multiple human tissues, based on proprietary Tissue Repair Cell Technology.

Recs

0
Player Avatar alphadogg (62.61) Submitted: 3/14/2011 7:56:29 AM : Outperform Start Price: $2.24 ASTM Score: -10.11

strong insider buying

Featured Broker Partners


Advertisement